Thromb Haemost 1981; 46(03): 597-601
DOI: 10.1055/s-0038-1653426
Original Article
Schattauer GmbH Stuttgart

Changes in Factor VIII Complex Activities During the Production of a Clinical Intermediate Purity Factor VIII Concentrate

C V Prowse
*   Edinburgh and South-East Scotland Blood Transfusion Service, Royal Infirmary, Edinburgh, U.K
,
B Griffin
+   Headquarters Unit Laboratory, Edinburgh, and Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh, U.K
,
D S Pepper
+   Headquarters Unit Laboratory, Edinburgh, and Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh, U.K
,
A J Dickson
The Scottish National Blood Transfusion Service, Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh, U.K
,
T A McQuillan
The Scottish National Blood Transfusion Service, Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh, U.K
,
I H Dickson
The Scottish National Blood Transfusion Service, Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh, U.K
,
P R Foster
The Scottish National Blood Transfusion Service, Protein Fractionation Centre, Ellen’s Glen Road, Edinburgh, U.K
› Author Affiliations
Further Information

Publication History

Received 17 March 1981

Accepted 24 June 1981

Publication Date:
05 July 2018 (online)

Preview

Summary

Samples taken at various stages of preparation of intermediate purity factor VIII concentrate were assayed for factor VIII coagulant activity (VIII:C), factor VIII coagulant antigen (VIIIC: Ag) and factor VIII related antigen (VIIIR: Ag). The antigen results were used to assess mechanical loss during fractionation as these markers are relatively stable. In contrast VIII:C is sensitive to both mechanical and inactivation losses.

The major loss of factor VIII occurred during the cryoprecipitation and extraction step and was due to both mechanical loss and inactivation. Losses before and after this step were largely due to inactivation of the factor VIII.

Assay of VIIIR: Ag in concentrates presented problems and a modified technique is suggested.